AAAAAA
Results:
1-22
|
Results: 22
Authors:
Kurzrock, R
Cortes, J
Thomas, DA
Jeha, S
Pilat, S
Talpaz, M
Citation: R. Kurzrock et al., Pilot study of low-dose interleukin-11 in patients with bone marrow failure, J CL ONCOL, 19(21), 2001, pp. 4165-4172
Authors:
Kurzrock, R
Bueso-Ramos, CE
Kantarjian, H
Freireich, E
Tucker, SL
Siciliano, M
Pilat, S
Talpaz, M
Citation: R. Kurzrock et al., BCR rearrangement-negative chronic myelogenous leukemia revisited, J CL ONCOL, 19(11), 2001, pp. 2915-2926
Authors:
Laurent, E
Talpaz, M
Kantarjian, H
Kurzrock, R
Citation: E. Laurent et al., The BCR gene and Philadelphia chromosome-positive leukemogenesis, CANCER RES, 61(6), 2001, pp. 2343-2355
Authors:
Kurzrock, R
Citation: R. Kurzrock, The role of cytokines in cancer-related fatigue, CANCER, 92(6), 2001, pp. 1684-1688
Authors:
Gisslinger, H
Kurzrock, R
Gisslinger, B
Jiang, SW
Li, SR
Virgolini, I
Woloszczuk, W
Andreeff, M
Talpaz, M
Citation: H. Gisslinger et al., Autocrine cell suicide in a Burkitt lymphoma cell line (Daudi) induced by interferon alpha: involvement of tumor necrosis factor as ligand for the CD95 receptor, BLOOD, 97(9), 2001, pp. 2791-2797
Authors:
Fayad, L
Keating, MJ
Reuben, JM
O'Brien, S
Lee, BN
Lerner, S
Kurzrock, R
Citation: L. Fayad et al., Interleukin-6 and interleukin-10 levels in chronic lymphocytic leukemia: correlation with phenotypic characteristics and outcome, BLOOD, 97(1), 2001, pp. 256-263
Authors:
Esmaeli, B
Ahmadi, A
Tang, R
Schiffman, J
Kurzrock, R
Citation: B. Esmaeli et al., Interferon therapy for orbital infiltration secondary to Erdheim-Chester disease, AM J OPHTH, 132(6), 2001, pp. 945-947
Authors:
Nash, RA
Kurzrock, R
DiPersio, J
Vose, J
Linker, C
Maharaj, D
Nademanee, AP
Negrin, R
Nimer, S
Shulman, H
Ashby, M
Jones, D
Appelbaum, FR
Champlin, R
Citation: Ra. Nash et al., A phase I trial of recombinant human thrombopoietin in patients with delayed platelet recovery after hematopoietic stem cell transplantation, BIOL BLOOD, 6(1), 2000, pp. 25-34
Authors:
Talpaz, M
Qiu, X
Cheng, K
Cortes, JE
Kantarjian, H
Kurzrock, R
Citation: M. Talpaz et al., Autoantibodies to Abl and Bcr proteins, LEUKEMIA, 14(9), 2000, pp. 1661-1666
Authors:
Laurent, E
Talpaz, M
Wetzler, M
Kurzrock, R
Citation: E. Laurent et al., Cytoplasmic and nuclear localization of the 130 and 160 kDa Bcr proteins, LEUKEMIA, 14(11), 2000, pp. 1892-1897
Authors:
Cohen, PR
Kurzrock, R
Citation: Pr. Cohen et R. Kurzrock, Sweet's syndrome: A neutrophilic dermatosis classically associated with acute onset and fever, CLIN DERMAT, 18(3), 2000, pp. 265-282
Authors:
Kurzrock, R
Citation: R. Kurzrock, Pentostatin (Nipent) in T-cell lymphomas, SEMIN ONCOL, 27(2), 2000, pp. 64-66
Authors:
Giles, FJ
Keating, AR
Kurzrock, R
Talpaz, M
Citation: Fj. Giles et al., A pilot study of recombinant human interleukin-4 therapy of myelofibrosis, J INTERF CY, 19(11), 1999, pp. 1253-1255
Authors:
Ravandi, F
Estrov, Z
Kurzrock, R
Breitmeyer, JB
Maschek, BJ
Talpaz, M
Citation: F. Ravandi et al., A phase I study of recombinant interferon-beta in patients with advanced malignant disease, CLIN CANC R, 5(12), 1999, pp. 3990-3998
Authors:
Beaupre, DM
Kurzrock, R
Citation: Dm. Beaupre et R. Kurzrock, RAS and leukemia: From basic mechanisms to gene-directed therapy, J CL ONCOL, 17(3), 1999, pp. 1071-1079
Authors:
Kurzrock, R
Pilat, S
Duvic, M
Citation: R. Kurzrock et al., Pentostatin therapy of T-cell lymphomas with cutaneous manifestations, J CL ONCOL, 17(10), 1999, pp. 3117-3121
Authors:
Cohen, PR
Kurzrock, R
Citation: Pr. Cohen et R. Kurzrock, 2-Chlorodeoxyadenosine-associated transient acantholytic dermatosis in hairy cell leukemia patients, AM J DERMAT, 21(1), 1999, pp. 106-107
Authors:
Diamandidou, E
Colome, M
Fayad, L
Duvic, M
Kurzrock, R
Citation: E. Diamandidou et al., Prognostic factor analysis in mycosis fungoides/Sezary syndrome, J AM ACAD D, 40(6), 1999, pp. 914-924
Authors:
Beaupre, DM
Kurzrock, R
Citation: Dm. Beaupre et R. Kurzrock, RAS inhibitors in hematologic cancers: Biologic considerations and clinical applications, INV NEW DR, 17(2), 1999, pp. 137-143
Authors:
Faderl, S
Talpaz, M
Estrov, Z
O'Brien, S
Kurzrock, R
Kantarjian, HM
Citation: S. Faderl et al., Mechanisms of disease - The biology of chronic myeloid leukemia, N ENG J MED, 341(3), 1999, pp. 164-172
Authors:
Beaupre, DM
Talpaz, M
Marini, FC
Cristiano, RJ
Roth, JA
Estrov, Z
Albitar, M
Freedman, MH
Kurzrock, R
Citation: Dm. Beaupre et al., Autocrine interleukin-1 beta production in leukemia: Evidence for the involvement of mutated RAS, CANCER RES, 59(12), 1999, pp. 2971-2980
Authors:
Faderl, S
Kurzrock, R
Estrov, Z
Citation: S. Faderl et al., Minimal residual disease in hematologic disorders, ARCH PATH L, 123(11), 1999, pp. 1030-1034
Risultati:
1-22
|